OKEP 07 March 2015

Is this your test? Login to manage it. If not, you can generate a quiz just like it.

This is a non-interactive preview of the quiz content.

1.
Name:
2.
Territory:
3.
Acinetobacter baumanii is gram negative bacilli and displays mechanism of resistance to all existing class of antibiotics.


4.
Which of the resistance mechanism may lead quinolone, aminoglycoside or tigecycline to be ineffective against acinetobacter species?
5.
What is the MIC90 of Kiviza as determined by agar dilution for 115 A.baumannii strains?


6.
Kiviza cannot be given in combination with carbapenem antibiotic.

7.
According to the study, X.Corbella et al, the activity of sulbactam alone was different to the activity of that of observed ampicillin/sulbactam combination in suscepitibility testing.
8.
Clinical study of Amoxicillin-sulbactam against A.baumanni shows optimal dose of kiviza should be_____________gm infused over_______________ with______hour interval through human ex-vivo model.
9.
What is the dosage of Kiviza when it is given in combination with suitable antibiotics?


10.
Can Kiviza be given to renal patients as monotherapy?

11.
Kiviza shows_______________ activity against A.baumanii infection.